Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients

R. Fujii, S. Chiba, K. Numazaki, T. Mori, I. Terashima, H. Meguro, A. Mori, Y. Toyonaga, K. Sunakawa, Y. Satoh, S. Iwata, H. Akita, N. Iwai

研究成果: Article査読

8 被引用数 (Scopus)

抄録

Carnitine metabolism was studied in 16 pediatric patients with various infections under the treatment with cefditoren pivoxil (CDTR-PI) in granular form. Pivalic acid released from pivaloyloxymethyl ester of the drug was metabolized to pivaloylcarnitine. As results, an increase in urinary carnitine excretion (predominantly as pivaloylcarnitine) and, a decrease in free carnitine concentration and a high acyl/free carnitine ratio in serum (plasma) were observed during the treatment. When the dosing was terminated, pivaloylcarnitine in plasma and then in urine disappeared, and the concentration of free carnitine, acyl/free carnitine ratio returned to the normal range. No carnitine-related side effects were observed throughout the study.

本文言語English
ページ(範囲)926-937
ページ数12
ジャーナルJapanese Journal of Antibiotics
46
10
出版ステータスPublished - 1993
外部発表はい

ASJC Scopus subject areas

  • 分子医療
  • 薬理学

フィンガープリント

「Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル